Metformin: An anti-diabetic drug to fight cancer
M Daugan, AD Wojcicki, B d'Hayer, V Boudy - Pharmacological research, 2016 - Elsevier
Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
[引用][C] Metformin: An anti-diabetic drug to fight cancer
M Daugan, AD Wojcicki, B d'Hayer… - Pharmacological Research, 2016 - cir.nii.ac.jp
Metformin: An anti-diabetic drug to fight cancer
M Daugan, AD Wojcicki, B d'Hayer, V Boudy - Pharmacological Research, 2016 - infona.pl
Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
Metformin: An anti-diabetic drug to fight cancer
M Daugan, AD Wojcicki, B d'Hayer… - Pharmacological …, 2016 - pubmed.ncbi.nlm.nih.gov
Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
Metformin: An anti-diabetic drug to fight cancer.
M Daugan, B d'Hayer, V Boudy - Pharmacological Research, 2016 - europepmc.org
Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …
incidence and mortality, many in vitro and in vivo studies as well as a large number of …